Raymond James Financial, Inc.

The forensic screens in the data point in a generally favorable direction, but they describe different things and should be read together. The Beneish M-Score is -2.447, which is below the -1.78 threshold and therefore not in the elevated manipulation-risk zone. That is a screening result only, not proof that the accounts are accurate. The Piotroski F-Score is 6 of 6 computable signals, meaning every signal that could be computed for fiscal 2025 was favorable; it is a checklist of financial strength and trend tests, not a measure of business quality. Operating cash flow divided by net income is 1.14, meaning fiscal 2025 cash generation exceeded reported profit, which is a useful check because reported earnings are backed by cash. Revenue growth was 6.6%. The Altman Z-Score and Fog Index are not on file for this review, so this summary does not rely on them. The balance sheet is large and heavily funded by liabilities: at fiscal year-end 2025, liabilities were $75.73 billion against $12.5 billion of equity, leaving equity at roughly 14% of $88.23 billion in assets. Because the company operates two FDIC-insured banks, the capital framework in the risk factors is central to reading its repurchase activity. The 10-Q states disclosure controls were concluded effective and that there were no changes in internal control over financial reporting, reports no legal proceedings, and says risk factors had no material changes since the 2025 10-K. Readers may want to look at the 10-K capital-rule discussion, Note 23, and the repurchase table in the 10-Q alongside the Fed guidance described in the risk factors.

Catalyst.Annual figures show revenues rising to $15.91 billion in fiscal 2025 from $14.92 billion in fiscal 2024, a 6.6% increase, and net income reaching $2.13 billion versus $2.07 billion. Operating cash flow was $2.43 billion, up from $2.15 billion. The 10-Q excerpt for the quarter ended March 31, 2026 contains no segment-level discussion of drivers, so this review cannot attribute growth to specific businesses. The filing does describe a Board authorization of up to $2 billion in share repurchases approved in December 2025, and it reports 5,146,629 shares acquired in the six months ended March 31, 2026, a total that also includes trust-fund and employee-surrender activity outside that authorization.

Hidden risk.The most easily missed tension is between capital return and bank capital rules. The 10-K says Basel III capital requirements could restrict growth and returning capital to shareholders. It also says the Fed would need prior approval for repurchases that reduce net worth by ten percent or more, and that Fed supervisors should prevent repurchases inconsistent with prospective capital needs. RJF must also serve as a source of financial strength for Raymond James Bank and TriState Capital Bank. Meanwhile the remaining authorization fell from $1,900 million at December 31, 2025 to $1,501 million at March 31, 2026. Cash flow has also been volatile, with operating cash flow of -$3.51 billion in fiscal 2023 and $72 million in fiscal 2022.